Elepsia™ XR (levetiracetam) – New drug approval
December 20, 2018 - The FDA approved Sun Pharma’s Elepsia XR (levetiracetam) extended-release tablets, as adjunctive therapy for the treatment of partial onset seizures in patients 12 years of age and older.
Download PDF
